Neurosteroid interactions with synaptic and extrasynaptic GABAA receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network …
Rationale Neurosteroids are steroids synthesized within the brain with rapid effects on
neuronal excitability. Allopregnanolone, allotetrahydrodeoxycorticosterone, and …
neuronal excitability. Allopregnanolone, allotetrahydrodeoxycorticosterone, and …
Allopregnanolone in mood disorders: Mechanism and therapeutic development
S Chen, L Gao, X Li, Y Ye - Pharmacological Research, 2021 - Elsevier
The neuroactive steroid allopregnanolone (ALLO) is an endogenous positive allosteric
modulator of GABA type A receptor (GABA AR), and the down-regulation of its biosynthesis …
modulator of GABA type A receptor (GABA AR), and the down-regulation of its biosynthesis …
Translocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effects
R Rupprecht, G Rammes, D Eser, TC Baghai, C Schüle… - Science, 2009 - science.org
Most antianxiety drugs (anxiolytics) work by modulating neurotransmitters in the brain.
Benzodiazepines are fast and effective anxiolytic drugs; however, their long-term use is …
Benzodiazepines are fast and effective anxiolytic drugs; however, their long-term use is …
Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs?
C Schüle, D Eser, TC Baghai, C Nothdurfter, JS Kessler… - Neuroscience, 2011 - Elsevier
In the past decades considerable evidence has emerged that so-called neuroactive steroids
do not only act as transcriptional factors in the regulation of gene expression but may also …
do not only act as transcriptional factors in the regulation of gene expression but may also …
Cortisol metabolic predictors of response to psychotherapy for symptoms of PTSD in survivors of the World Trade Center attacks on September 11, 2001
BACKGROUND: A proportion of subjects with symptoms of posttraumatic stress disorder
(PTSD) are unresponsive to specialized psychotherapy, but a biological basis for this has …
(PTSD) are unresponsive to specialized psychotherapy, but a biological basis for this has …
Anxiolytic-like effects of YL-IPA08, a potent ligand for the translocator protein (18 kDa) in animal models of post-traumatic stress disorder
LM Zhang, ZK Qiu, N Zhao, HX Chen… - International Journal …, 2014 - academic.oup.com
Recently, the translocator protein (18 kDa)(TSPO), previously called peripheral
benzodiazepine receptor (PBR) and both the starting point and an important rate-limiting …
benzodiazepine receptor (PBR) and both the starting point and an important rate-limiting …
[HTML][HTML] Neurosteroids reduce social isolation-induced behavioral deficits: a proposed link with neurosteroid-mediated upregulation of BDNF expression
MS Nin, LA Martinez, F Pibiri, M Nelson… - Frontiers in …, 2011 - frontiersin.org
The pharmacological action of selective serotonin reuptake inhibitor antidepressants may
include a normalization of the decreased brain levels of the brain-derived neurotrophic …
include a normalization of the decreased brain levels of the brain-derived neurotrophic …
Regulation of anxiety and depression by mitochondrial translocator protein-mediated steroidogenesis: the role of neurons
Pharmacological studies have implicated the translocator protein (TSPO) in the regulation of
complex behaviors including anxiety and depression, effects thought to be mediated by …
complex behaviors including anxiety and depression, effects thought to be mediated by …
[HTML][HTML] Neurosteroids—endogenous regulators of seizure susceptibility and role in the treatment of epilepsy
DS Reddy, MA Rogawski - 2012 - europepmc.org
Certain steroid hormone metabolites that have activity as modulators of GABAA receptors
but lack conventional hormonal effects—including allopregnanolone and …
but lack conventional hormonal effects—including allopregnanolone and …
Enhancing neurosteroid synthesis–relationship to the pharmacology of translocator protein (18 kDa)(TSPO) ligands and benzodiazepines
L Wolf, A Bauer, D Melchner… - …, 2015 - thieme-connect.com
Introduction: The treatment of anxiety disorders is still a challenge; novel pharmacological
approaches that combine rapid anxiolytic efficacy with fewer side effects are needed. A …
approaches that combine rapid anxiolytic efficacy with fewer side effects are needed. A …